What is Sutro Biopharma's net margin?

Sutro Biopharma (STRO) reported net margin of -154.2% in Q1 2026.

How has Sutro Biopharma's net margin changed year-over-year?

Sutro Biopharma's net margin increased by 58.2% year-over-year, from -369.1% to -154.2%.

What is the long-term trend for Sutro Biopharma's net margin?

Over 4 years (2020 to 2025), Sutro Biopharma's net margin has grown at a 25.5% compound annual growth rate (CAGR), from -75.2% to -186.5%.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Sutro Biopharma STRO Net margin

Net margin at other companies

PfizerPFE

15.7%—

Gilead SciencesGILD

31%+10.2pp

RegenxbioRGNX

-330.2%-588pp

XencorXNCR

-177.1%+16.5pp

AnaptysBio, Inc.ANAB

-49.9%-22.6pp

SchrodingerSDGR

-68.5%—

Other financials

Income statement

See full

Revenue$14.5M-16.5%

Operating income-$29.7M+56.7%

Net income-$38.5M+49.3%

EPS (diluted)-$2.94+67.6%

Balance sheet

See full

Cash & equivalents$73.7M-30.6%

Total debt$13.6M-36.3%

Total equity-$66.9M-159%

Total assets$242.0M-24.7%

Cash flow

See full

Operating cash flow-$42.3M+37.7%

CapEx--100%

Free cash flow-$42.3M+37.8%

Valuation

See full

Market cap$489.66M+624%

Enterprise value$429.61M-2,600%

P/S4.9×+3.9×

Profitability

See full

Operating margin-120%-48.6pp

FCF margin-152.2%-51.1pp

Returns & leverage

See full

Return on equity-234.2%—

Debt / equity0.5×+0.3×

Current ratio3.1×+1.0×

Where this comes from

Calculated from Sutro Biopharma’s reported figures.

net income/total revenue=-154.2%

Based on trailing twelve months.

The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sutro Biopharma's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sutro Biopharma's net margin?: Sutro Biopharma (STRO) reported net margin of -154.2% in Q1 2026.
How has Sutro Biopharma's net margin changed year-over-year?: Sutro Biopharma's net margin increased by 58.2% year-over-year, from -369.1% to -154.2%.
What is the long-term trend for Sutro Biopharma's net margin?: Over 4 years (2020 to 2025), Sutro Biopharma's net margin has grown at a 25.5% compound annual growth rate (CAGR), from -75.2% to -186.5%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.